Mark M. Sieczkarek, Director at SOLTA MEDICAL INC (SLTM), bought 150,000 shares at $1.74 ($261K) on 2013-05-06, disclosed to the SEC on 2013-05-07.
Open-market purchase of $261k SLTM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| NBY | BUY | 2014-05-21 | $22K | — | Filing → |
| CPTS | SELL | 2010-02-23 | $1.5M | — | Filing → |
| CPTS | SELL | 2010-01-22 | $2.0M | — | Filing → |